Serum myeloperoxidase in stable coronary artery disease

Vijetha Shenoy Belle, K. Ranjan Shetty, Krishnananda Prabhu, Rajaram Prasad, Pragna Rao

Research output: Contribution to journalArticle

Abstract

An inflammatory marker myeloperoxidase (MPO) is stored in the granules of neutrophils and monocytes released in response to leukocyte activation. High concentration of MPO can induce inflammation which can trigger plaque formation leading to atherosclerosis. But its role in stable coronary artery disease (CAD) is limited. The objectives were to measure and compare the serum MPO levels in stable coronary artery patients and controls and to correlate serum MPO with severity of stable coronary artery disease. After obtaining ethical clearance, the study was conducted in Department of Biochemistry Kasturba Medical College Manipal in collaboration with Department of Cardiology, Kasturba Hospital Manipal. Total 86 samples (controls 36, cases 50) were collected in red capped vacutainer. Serum myeloperoxidase was measured using ELISA kit method. Non parametric tests, correlations were used wherever appropriate. p<0.05 was said to statically significant. Median values of serum myeloperoxidase levels in cases (28.13 ng/mL) were significantly increased as compared to that of controls (10.05 ng/mL), p value being <0.001. Serum MPO significantly correlated with severity of stable CAD. To conclude serum Myeloperoxidase levels significantly correlated with severity of stable coronary artery disease. Thus serum MPO has a potential to be used for risk stratification and in assessing prognosis of such cases.

Original languageEnglish
Pages (from-to)1785-1788
Number of pages4
JournalAdvanced Science Letters
Volume23
Issue number3
DOIs
Publication statusPublished - 01-03-2017

Fingerprint

Coronary Artery Disease
Peroxidase
serum
Disease
Serum
Cardiology
Biochemistry
biochemistry
Monocytes
Neutrophils
Atherosclerosis
Enzyme-linked Immunosorbent Assay
Leukocytes
Inflammation
Case-control
cardiology
Coronary Artery
activation
Non-parametric test
Prognosis

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Computer Science(all)
  • Education
  • Mathematics(all)
  • Environmental Science(all)
  • Engineering(all)
  • Energy(all)

Cite this

Belle, Vijetha Shenoy ; Shetty, K. Ranjan ; Prabhu, Krishnananda ; Prasad, Rajaram ; Rao, Pragna. / Serum myeloperoxidase in stable coronary artery disease. In: Advanced Science Letters. 2017 ; Vol. 23, No. 3. pp. 1785-1788.
@article{e25389da62884f94982749210fb90ec2,
title = "Serum myeloperoxidase in stable coronary artery disease",
abstract = "An inflammatory marker myeloperoxidase (MPO) is stored in the granules of neutrophils and monocytes released in response to leukocyte activation. High concentration of MPO can induce inflammation which can trigger plaque formation leading to atherosclerosis. But its role in stable coronary artery disease (CAD) is limited. The objectives were to measure and compare the serum MPO levels in stable coronary artery patients and controls and to correlate serum MPO with severity of stable coronary artery disease. After obtaining ethical clearance, the study was conducted in Department of Biochemistry Kasturba Medical College Manipal in collaboration with Department of Cardiology, Kasturba Hospital Manipal. Total 86 samples (controls 36, cases 50) were collected in red capped vacutainer. Serum myeloperoxidase was measured using ELISA kit method. Non parametric tests, correlations were used wherever appropriate. p<0.05 was said to statically significant. Median values of serum myeloperoxidase levels in cases (28.13 ng/mL) were significantly increased as compared to that of controls (10.05 ng/mL), p value being <0.001. Serum MPO significantly correlated with severity of stable CAD. To conclude serum Myeloperoxidase levels significantly correlated with severity of stable coronary artery disease. Thus serum MPO has a potential to be used for risk stratification and in assessing prognosis of such cases.",
author = "Belle, {Vijetha Shenoy} and Shetty, {K. Ranjan} and Krishnananda Prabhu and Rajaram Prasad and Pragna Rao",
year = "2017",
month = "3",
day = "1",
doi = "10.1166/asl.2017.8512",
language = "English",
volume = "23",
pages = "1785--1788",
journal = "Advanced Science Letters",
issn = "1936-6612",
publisher = "American Scientific Publishers",
number = "3",

}

Belle, VS, Shetty, KR, Prabhu, K, Prasad, R & Rao, P 2017, 'Serum myeloperoxidase in stable coronary artery disease', Advanced Science Letters, vol. 23, no. 3, pp. 1785-1788. https://doi.org/10.1166/asl.2017.8512

Serum myeloperoxidase in stable coronary artery disease. / Belle, Vijetha Shenoy; Shetty, K. Ranjan; Prabhu, Krishnananda; Prasad, Rajaram; Rao, Pragna.

In: Advanced Science Letters, Vol. 23, No. 3, 01.03.2017, p. 1785-1788.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum myeloperoxidase in stable coronary artery disease

AU - Belle, Vijetha Shenoy

AU - Shetty, K. Ranjan

AU - Prabhu, Krishnananda

AU - Prasad, Rajaram

AU - Rao, Pragna

PY - 2017/3/1

Y1 - 2017/3/1

N2 - An inflammatory marker myeloperoxidase (MPO) is stored in the granules of neutrophils and monocytes released in response to leukocyte activation. High concentration of MPO can induce inflammation which can trigger plaque formation leading to atherosclerosis. But its role in stable coronary artery disease (CAD) is limited. The objectives were to measure and compare the serum MPO levels in stable coronary artery patients and controls and to correlate serum MPO with severity of stable coronary artery disease. After obtaining ethical clearance, the study was conducted in Department of Biochemistry Kasturba Medical College Manipal in collaboration with Department of Cardiology, Kasturba Hospital Manipal. Total 86 samples (controls 36, cases 50) were collected in red capped vacutainer. Serum myeloperoxidase was measured using ELISA kit method. Non parametric tests, correlations were used wherever appropriate. p<0.05 was said to statically significant. Median values of serum myeloperoxidase levels in cases (28.13 ng/mL) were significantly increased as compared to that of controls (10.05 ng/mL), p value being <0.001. Serum MPO significantly correlated with severity of stable CAD. To conclude serum Myeloperoxidase levels significantly correlated with severity of stable coronary artery disease. Thus serum MPO has a potential to be used for risk stratification and in assessing prognosis of such cases.

AB - An inflammatory marker myeloperoxidase (MPO) is stored in the granules of neutrophils and monocytes released in response to leukocyte activation. High concentration of MPO can induce inflammation which can trigger plaque formation leading to atherosclerosis. But its role in stable coronary artery disease (CAD) is limited. The objectives were to measure and compare the serum MPO levels in stable coronary artery patients and controls and to correlate serum MPO with severity of stable coronary artery disease. After obtaining ethical clearance, the study was conducted in Department of Biochemistry Kasturba Medical College Manipal in collaboration with Department of Cardiology, Kasturba Hospital Manipal. Total 86 samples (controls 36, cases 50) were collected in red capped vacutainer. Serum myeloperoxidase was measured using ELISA kit method. Non parametric tests, correlations were used wherever appropriate. p<0.05 was said to statically significant. Median values of serum myeloperoxidase levels in cases (28.13 ng/mL) were significantly increased as compared to that of controls (10.05 ng/mL), p value being <0.001. Serum MPO significantly correlated with severity of stable CAD. To conclude serum Myeloperoxidase levels significantly correlated with severity of stable coronary artery disease. Thus serum MPO has a potential to be used for risk stratification and in assessing prognosis of such cases.

UR - http://www.scopus.com/inward/record.url?scp=85018593684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018593684&partnerID=8YFLogxK

U2 - 10.1166/asl.2017.8512

DO - 10.1166/asl.2017.8512

M3 - Article

AN - SCOPUS:85018593684

VL - 23

SP - 1785

EP - 1788

JO - Advanced Science Letters

JF - Advanced Science Letters

SN - 1936-6612

IS - 3

ER -